finance.foundation / Companies / AZN vs JNJ
Comparison · seed-0.6 · 2026-08-29
AstraZeneca (AZN) vs Johnson & Johnson (JNJ)
AstraZeneca (AZN) and Johnson & Johnson (JNJ) side by side: both in Healthcare, listed on London Stock Exchange and New York Stock Exchange. Johnson & Johnson is the larger of the two by approximate market capitalization (about 1.7×).
| Field | AstraZeneca | Johnson & Johnson |
|---|---|---|
| Legal name | AstraZeneca PLC | Johnson & Johnson |
| Ticker | AZN | JNJ |
| Exchange | London Stock Exchange XLON | New York Stock Exchange XNYS |
| Jurisdiction | United Kingdom | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharma & MedTech |
| Market cap ≈ | $230bn | $380bn |
| Founded | 1999 | 1886 |
| Reporting currency | GBP | USD |
| LEI | PY6ZZQWO2IZFZC3IOL08 | 549300G0CFPGEF6X2043 |
| ISIN | GB0009895292 | US4781601046 |
| FIGI | BBG001SCNW31 | BBG001S5SHQ9 |
| Index membership | FTSE 100 | S&P 500 |
| Held by (covered funds) | — | — |
AstraZeneca
Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/astrazeneca · /api/v1/companies/johnson-johnson